(1)
Pharmacotherapeutic and Laboratory Profile Analysis of Patients With Secondary Hyperparathyroidism Submitted to Parathyroidectomy. RSD 2022, 11 (5), e16511527949. https://doi.org/10.33448/rsd-v11i5.27949.